Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Microfluidic devices as model platforms of CNS injury-ischemia to study axonal regeneration by regulating mitochondrial transport and bioenergetic metabolism
Age and gender recognition using a convolutional neural network with a specially designed multi-attention module through speech spectrograms
Which Medication Is More Effective
Rationale and design of a randomized, double-blind, Placebo-controlled study to evaluate the efficacy and safety of AKST4290 in subjects with Parkinsons disease on stable Dopaminergic treatment
The drugmaker says patients typically start a dose of 0.25 mg once weekly for four weeks before upping the dose in intervals, reaching 2.4 mg
US$ 23.32
US$ 25.73
US$ 22.11
US$ 24.36
US$ 22.92
US$ 27.60
US$ 26.75
US$ 20.37
